Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Bausch + Lomb Corporation
Bausch + Lomb Corporation
BLCO
Valuace
78
Růst
8
Zdraví
61
Cena
$ 15.99
Dnes
--0.28 (-1.61%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
5.7B
Obrat
5B
Zisk
0B
Aktiva
14B
Dluh
5B
ROE
0%
ROA
0%
PE
-15
PS
1
Cena 1R
10-18
⌀ Cena
14.29
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
18-02-2026
Poslední dividenda

Profil

Bausch + Lomb Corporation působí jako oční zdravotní společnost po celém světě. Působí ve třech segmentech: Vizuální péče / péče o spotřebitele, oftalmologická léčiva a chirurgie. Segment Vision Care/Consumer Health Care poskytuje kontaktní čočky, které pokrývají spektrum způsobů nošení, včetně denních jednorázových a často vyměňovaných kontaktních čoček; a produkty pro péči o kontaktní čočky, volně prodejné oční kapky, oční vitamíny a minerální doplňky, které řeší různé stavy zahrnující oční alergie, konjunktivitidu a suché oko. Segment oftalmologických léčiv nabízí patentované a generické farmaceutické přípravky pro pooperační léčbu, stejně jako pro léčbu očních stavů, jako je glaukom, oční hypertenze a onemocnění sítnice; a kontaktní čočky pro terapeutické použití. Chirurgický segment poskytuje nástroje a technologie pro léčbu šedého zákalu a sklivcových a retinálních očních stavů; a nitrooční čočky a aplikační systémy, zařízení pro fyzioemulgaci a další chirurgické nástroje a přístroje. Společnost byla založena v roce 1853 a sídlí v kanadském Vaughanu.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
13500
Založení
2022-05-06
Adresa
520 Applewood Crescent
CEO
Brenton L. Saunders
Web
www.bausch.com

Podobné společnosti

TFX
Teleflex Incorporated
$ 107.94
- $ 1.46
MMSI
Merit Medical Systems, Inc.
$ 88.16
+ $ 0.61
PCVX
Vaxcyte, Inc.
$ 42.05
+ $ 0.40
CRSP
CRISPR Therapeutics AG
$ 54.30
- $ 0.82
ARWR
Arrowhead Pharmaceuticals, Inc.
$ 40.77
+ $ 1.54
PTCT
PTC Therapeutics, Inc.
$ 70.79
- $ 1.00
GKOS
Glaukos Corporation
$ 86.69
+ $ 2.83

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues5,101.05,101.04,791.04,146.03,768.03,765.03,412.03,778.03,665.0
Cost of Revenues2,106.02,106.01,872.01,642.01,519.01,467.01,285.01,327.01,313.0
Gross Profit2,995.02,995.02,919.02,504.02,249.02,298.02,127.02,451.02,352.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues1,405.01,281.01,278.01,137.01,280.01,196.01,216.01,099.01,173.01,007.0
Cost of Revenues589.0510.0525.0482.0501.0464.0483.0424.0461.0392.0
Gross Profit816.0771.0753.0655.0779.0732.0733.0675.0712.0615.0
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.00.00.0324.0307.0271.0253.0258.0221.0
Selling General & Admin Expenses0.00.00.01,736.01,478.01,389.01,253.01,382.01,327.0
Depreciation & Amortization421.0421.0436.0382.0250.0456.0490.0469.0495.0
Total Operating Expenses2,836.02,836.02,757.02,374.02,029.01,952.01,829.01,988.01,925.0
Operating Income159.0159.0162.0130.0207.0329.0260.0532.0416.0
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.080.082.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0483.0418.0
Depreciation & Amortization99.0109.0107.0106.0106.0110.0110.0110.0116.082.0
Total Operating Expenses658.0676.0764.0738.0692.0689.0707.0669.0643.0547.0
Operating Income158.095.0-11.0-83.087.043.026.06.049.040.0
Net Income TTM 20252024202320222021202020192018
Interest Income12.012.015.015.06.00.03.01.00.0
Interest Expense431.0431.0399.0283.0146.00.00.00.08.0
Other Expense-476.0-476.0-396.0-296.0-134.0-11.030.0-133.0-10.0
IBT-317.0-317.0-234.0-166.073.0318.0290.0399.0417.0
Income Tax Expense35.035.071.082.058.0125.0307.096.0-302.0
Net Income-360.0-360.0-317.0-260.015.0182.0-17.0298.0710.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income3.03.03.03.05.04.03.03.03.04.0
Interest Expense108.0101.0128.094.098.0100.0102.099.099.076.0
Other Expense-145.0-98.0-136.0-97.0-97.0-101.0-102.0-96.0-106.0-75.0
IBT13.0-3.0-147.0-180.0-10.0-58.0-76.0-90.0-57.0-35.0
Income Tax Expense71.022.0-89.031.0-8.0-66.072.073.0-6.045.0
Net Income-58.0-28.0-62.0-212.0-3.04.0-151.0-167.0-54.0-84.0
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-0.74$0.04$0.52$-0.05$0.85$2.03
EPS Diluted$0.00$0.00$0.00$-0.74$0.04$0.52$-0.05$0.85$2.03
Shares Outstanding353.8353.8351.8350.5350.0350.0350.0350.0350.0
Diluted Shares Outstanding353.8353.8351.8350.5350.2350.0350.0350.0350.0
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.15$-0.24
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.15$-0.24
Shares Outstanding353.8354.2353.7352.8351.8351.9351.8351.1350.8350.8
Diluted Shares Outstanding353.8354.2353.7352.8351.8353.9351.8351.1350.8350.8
Current Assets TTM 202420232022202120202019
Cash And Equivalents302.0305.0331.0354.0174.0238.0192.0
Short Term Investments0.00.00.00.00.00.00.0
Total Cash & ST Investments302.0305.0331.0354.0174.0238.0192.0
Accounts Receivable1,010.01,026.0839.0724.0721.0645.0713.0
Inventory1,069.01,036.01,028.0628.0572.0616.0592.0
Other Current Assets388.0421.0544.0431.0165.0155.0198.0
Total Current Assets2,769.02,788.02,742.02,137.01,635.01,654.01,695.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents310.0272.0202.0305.0329.0302.0325.0331.0355.0384.0
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments310.0272.0202.0305.0329.0302.0325.0331.0355.0384.0
Accounts Receivable1,094.01,088.01,007.01,026.0943.01,010.0960.0839.0783.0791.0
Inventory1,005.01,051.01,031.01,036.01,119.01,069.01,073.01,028.0754.0699.0
Other Current Assets451.0435.0454.0421.0437.0388.0385.01,042.01,078.0787.0
Total Current Assets2,855.02,846.02,694.02,788.02,828.02,769.02,743.02,742.02,464.02,315.0
Long-Term Assets TTM 202420232022202120202019
Net Property, Plant & Equipment1,430.01,485.01,390.01,300.01,225.01,164.0997.0
Goodwill4,538.04,523.04,575.04,507.04,586.04,685.04,554.0
Intangible Assets3,437.03,494.03,589.02,058.02,264.02,562.02,855.0
Long-Term Investments19.019.00.00.00.00.00.0
Other Long-Term Assets230.0275.0225.0215.0180.0165.0175.0
Total Long-Term Assets10,481.010,681.010,700.09,007.09,188.09,612.09,773.0
Total Assets13,250.013,469.013,442.011,144.010,823.011,266.011,468.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1,711.01,680.01,581.01,485.01,481.01,430.01,397.01,390.01,284.01,294.0
Goodwill4,657.04,667.04,567.04,523.04,581.04,538.04,547.04,575.04,526.04,540.0
Intangible Assets3,328.03,361.03,427.03,494.03,384.03,437.03,515.03,589.03,662.02,021.0
Long-Term Investments0.07.07.019.019.019.019.019.012.012.0
Other Long-Term Assets303.0298.0288.0275.0291.0230.0212.0206.0200.0195.0
Total Long-Term Assets10,977.010,986.010,734.010,681.010,687.010,481.010,550.010,700.010,604.09,000.0
Total Assets13,832.013,832.013,428.013,469.013,515.013,250.013,293.013,442.013,068.011,315.0
Current Liabilities TTM 202420232022202120202019
Accounts Payable405.0389.0522.0370.0239.0178.0262.0
Short-Term Debt30.072.030.025.00.00.00.0
Other Current Liabilities1,241.01,277.01,027.0901.0860.0731.0773.0
Current Liabilities1,676.01,738.01,579.01,296.01,099.0909.01,035.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable395.0449.0427.0389.0455.0405.0426.0522.0364.0348.0
Short-Term Debt28.028.040.072.030.030.030.030.030.025.0
Other Current Liabilities1,473.01,363.01,259.01,277.01,249.01,241.01,161.01,027.0992.0952.0
Current Liabilities1,896.01,840.01,726.01,738.01,801.01,676.01,617.01,579.01,386.01,325.0
Long-Term Liabilities TTM 202420232022202120202019
Long-Term Debt4,602.04,864.04,619.02,411.00.00.00.0
Capital Leases0.0152.087.00.00.00.00.0
Def. Tax Liability14.013.014.07.024.027.038.0
Total Liabilities6,670.06,925.06,522.04,043.01,421.01,278.01,436.0
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt4,922.04,931.04,789.04,864.04,599.04,602.04,554.04,619.04,435.02,604.0
Capital Leases0.00.00.0152.00.00.00.087.00.00.0
Def. Tax Liability14.014.013.013.012.014.014.014.011.014.0
Total Liabilities7,332.07,324.06,995.06,925.06,854.06,670.06,564.06,522.06,185.04,285.0
Total Common Equity TTM 202420232022202120202019
Common Stock0.00.00.00.010,364.010,807.011,005.0
Retained Earnings-572.0-571.0-254.06.00.00.00.0
Comprehensive Income-1,306.0-1,385.0-1,245.0-1,258.0-1,035.0-889.0-1,046.0
Total Common Equity6,504.06,473.06,850.07,033.09,329.09,918.09,959.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-873.0-845.0-783.0-571.0-568.0-572.0-421.0-254.0-200.0-116.0
Comprehensive Income-1,198.0-1,191.0-1,304.0-1,385.0-1,248.0-1,306.0-1,283.0-1,245.0-1,317.0-1,247.0
Total Common Equity6,429.06,440.06,361.06,473.06,589.06,504.06,659.06,850.06,817.06,958.0
Other TTM 202420232022202120202019
Total Debt4,632.04,936.04,562.02,436.00.00.00.0
Book Value6,580.06,544.06,920.07,101.09,402.09,988.010,032.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt71.068.072.071.072.076.070.070.066.072.0
Book Value6,429.06,440.06,361.06,473.06,589.06,504.06,659.06,850.06,817.06,958.0
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-449.0-352.0-305.0-248.015.0193.0-17.0303.0719.0
Depreciation & Amortization418.0421.0436.0382.0379.0415.0442.0469.0495.0
Stock-Based Compensation73.0149.092.074.062.062.050.050.043.0
Change Working Capital-102.018.0-87.0-287.0-19.028.0-59.0-40.0-78.0
Change In Accounts Receivable-211.8-148.0-227.0-121.0-95.0-107.077.0-21.0-9.0
Change In Accounts Payable380.0108.0126.0245.0189.0163.0-144.078.0-19.0
Change In Inventories-294.238.0-147.0-264.0-106.0-15.0-32.0-91.0-7.0
Other Non-cash Items722.179.0106.072.0-2.059.09.056.028.0
Cash from Operations118.60.00.0-17.0345.0873.0522.0799.0763.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-58.0-28.0-58.0-211.0-2.08.0-148.0-163.0-51.0-80.0
Depreciation & Amortization99.0109.0107.0106.0106.0110.0110.0110.0116.082.0
Stock-Based Compensation0.00.030.028.027.024.022.019.016.016.0
Change Working Capital-68.337.448.00.0-182.098.0-14.011.0-100.01.0
Change In Accounts Receivable-130.0-14.2-50.046.0-119.058.0-74.0-92.0-39.0-8.0
Change In Accounts Payable-3.536.397.0-23.0-107.094.069.070.0188.054.0
Change In Inventories27.920.32.0-12.014.0-48.0-27.0-86.0-120.0-62.0
Other Non-cash Items96.225.417.034.045.120.021.020.035.019.0
Cash from Operations0.00.00.00.00.00.00.00.015.048.0
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-252.0-349.0-291.0-181.0-175.0-209.0-259.0-180.0-101.0
Acquisitions-1,908.00.00.0-1,941.045.016.06.00.00.0
Investments-13.0-11.0-12.0-17.0-62.0-19.0-6.0-16.0-7.0
Sales of Investment13.08.014.016.022.014.09.010.07.0
Other Investing Activities12.80.00.014.0-45.0-16.0-6.00.027.0
Cash from Investing-2,147.10.00.0-2,109.0-215.0-214.0-256.0-186.0-74.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-72.5-74.5-89.0-110.0-92.8-60.0-72.0-67.0-84.0-30.0
Acquisitions-0.17.10.0-12.0-91.0-45.0-1.0-1.0-49.0-1,861.0
Investments-114.0-1.0-1.0-4.0-5.0-2.0-3.0-2.0-4.0-2.0
Sales of Investment1.91.01.04.02.84.01.06.02.04.0
Other Investing Activities0.00.00.00.00.00.00.00.0-0.27.0
Cash from Investing0.00.00.00.00.00.00.00.0-135.0-1,882.0
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid-207.60.00.02,115.0-13.00.00.00.00.0
Debt Issued2,210.64,936.0374.04,241.02,449.00.00.00.00.0
Issuance of Common Stock0.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-12.00.0-12.0-10.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.0
Other Financing Activities2,040.10.00.0-37.094.0-712.0-232.0-606.0-665.0
Cash from Financing1,948.60.00.02,078.081.0-712.0-232.0-606.0-665.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.061.61,839.0
Debt Issued4,950.0-9.0130.0-107.0307.0-3.048.022.0158.63,675.0
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.0-2.00.0-3.00.00.00.0-1.0-3.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.025.4-25.0
Cash from Financing0.00.00.00.00.00.00.00.086.01,811.0
Cash position TTM 20252024202320222021202020192018
Net Change in Cash-90.081.0-18.0-46.0203.0-61.046.04.016.0
Closing Cash Balance302.0397.0316.0334.0380.0177.0238.0192.0188.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash65.060.057.0-101.0-34.048.0-23.0-9.0-26.0-32.0
Closing Cash Balance397.0332.0272.0215.0316.0350.0302.0325.0334.0360.0
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-133.4-66.0-59.0-198.0170.0664.0263.0619.0662.0
Real Free Cash Flow-206.4-215.0-151.0-272.0108.0602.0213.0569.0619.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow61.864.5-54.0-135.0-70.094.0-57.0-26.0-69.018.0
Real Free Cash Flow61.864.5-84.0-163.0-97.070.0-79.0-45.0-85.02.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-15.437.21703.4
P/S1.11.367.9
P/B0.90.825.8
P/FCF-46.1-1.2396.3
Market cap$5.7$5.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %21.4 %0 %
Debt to Income-1375 %588.9 %0 %
Debt to Free cash flow-4102.1 %-0.2 %0 %
Interest expense percentage271.1 %198.4 %38.7 %
Current ratio1.5 1.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-5.6 %-2.4 %0 %
ROA-2.6 %-1.2 %0 %
CapEx to Revenue6.8 %5.8 %10.6 %
RaD to Revenue0 %6.8 %0 %
ROEM377,851.9 370683.2

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin58.7 %59.5 %79.8 %
Operating margin3.1 %5.1 %29.6 %
Net margin-7.1 %-5.3 %27.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding353.8 mil 351.2 mil
Employee count13.5 tis 7.3 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader